Key facts
- Notable investors include MedTech Innovator, New York Angels, Neman Ventures, Symbiotic Ventures, MedTech Angels — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for CardiaCare
- ·The full record, as it builds
Funding rounds
No funding rounds for CardiaCare are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About CardiaCare
Developer of a wearable device designed for non-invasive treatment and monitoring of atrial fibrillation at home. The company's device is based on a closed-loop approach and machine learning algorithms that utilize non-invasive, personalized peripheral neuromodulation to mediate a cardiovascular antiarrhythmic response, enabling patients to reduce the burden of atrial fibrillation and its precursors, resulting in fast clinical and symptomatic relief.
- Sector
- Healthcare
- HQ
- Rehovot, Israel
- Founded
- 2018
- Employees
- 6
- Website
- my-cardiacare.com/
- Ownership
- Privately Held (backing)
CardiaCare doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in CardiaCare shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on CardiaCare in its N-PORT filings yet. We sweep new filings monthly.